Gentium requests Re-examination of opinion by EMA Gentium announced that, the Company has filed the documentation requesting a Re-examination of the negative opinion given by the European Medicines Agency's, or EMA, Committee for Medicinal Products for Human Use regarding the Marketing Authorisation for Defibrotide to treat and prevent hepatic ... (more)
http://www.theflyonthewall.com/permalinks/entry.php/GENTid1841565/GENT-Gentium-requests-Reexamination-of-opinion-by-EMA
http://www.theflyonthewall.com/permalinks/entry.php/GENTid1841565/GENT-Gentium-requests-Reexamination-of-opinion-by-EMA
No comments:
Post a Comment